WAT
NYSE · Life Sciences Tools & Services
Waters Corp
$381.29
+4.40 (+1.17%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.89B | 2.84B | 9.45B | 9.29B | 7.43B |
| Net Income | 624.14M | 550.60M | 1.34B | 1.34B | 880.25M |
| EPS | — | — | — | — | — |
| Profit Margin | 21.6% | 20.5% | 14.2% | 14.5% | 11.8% |
| Rev Growth | +2.0% | +2.0% | +13.9% | -0.3% | -5.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 5.23B | 5.23B | 4.59B | 4.54B | 5.20B |
| Total Equity | 5.88B | 5.88B | 6.47B | 7.11B | 7.03B |
| D/E Ratio | 0.89 | 0.89 | 0.71 | 0.64 | 0.74 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 856.52M | 797.58M | 2.67B | 2.41B | 2.08B |
| Free Cash Flow | — | — | 1.11B | 970.87M | 668.96M |